1. Home
  2. EEX vs EVMN Comparison

EEX vs EVMN Comparison

Compare EEX & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emerald Holding Inc.

EEX

Emerald Holding Inc.

HOLD

Current Price

$4.53

Market Cap

880.2M

ML Signal

HOLD

EVMN

Evommune Inc.

N/A

Current Price

$23.80

Market Cap

892.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EEX
EVMN
Founded
2013
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
880.2M
892.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EEX
EVMN
Price
$4.53
$23.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$7.70
$43.29
AVG Volume (30 Days)
26.1K
286.3K
Earning Date
03-13-2026
03-05-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.49
N/A
Revenue Next Year
$6.81
N/A
P/E Ratio
$236.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.22
$13.89
52 Week High
$5.45
$33.20

Technical Indicators

Market Signals
Indicator
EEX
EVMN
Relative Strength Index (RSI) 51.76 48.97
Support Level $4.47 $21.40
Resistance Level $5.16 $33.20
Average True Range (ATR) 0.23 2.04
MACD 0.04 -0.31
Stochastic Oscillator 81.54 45.34

Price Performance

Historical Comparison
EEX
EVMN

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.

About EVMN Evommune Inc.

Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.

Share on Social Networks: